What Happened?
Richmond, CA-based DiaCarta Appointed Aiguo Zhang as President and Chief Executive Officer
About the Company
DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world.
About the Person
Aiguo Zhang is President and Chief Executive Officer at DiaCarta. Previously, Aiguo held various senior HR leadership roles in the industry.
Info Source
News
Short Profile